drugset / Trial / NCT01352611
Open Label Treatment of Severe Tactile Defensiveness With Intrathecal Baclofen
Withdrawn
University of Missouri-Columbia
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if intrathecal administration of baclofen can reduce symptoms of severe tactile defensiveness and autism spectrum disorder.
Timeline
- Start
- 2014-09
- Primary completion
- 2015-04
- Completion
- 2015-04
Publications
- Background Farid, R.S., Nevel, R. and Murdock, F. Effect of Intrathecal Baclofen on Severe Tactile Defensiveness and Symptoms of Autism Spectrum Disorder. Abstract. International Meeting for Autism Research, Philadelphia, PA. May, 2010.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Baclofen | Small molecule | 50 ug | Intrathecal |